FDA Cites Latisse Web Site For Implying Eyelash Growth Drug Is A Cosmetic

摘要

Allergan' s consumer Web site for its eyelash growth drug Latisse certainly caught FDA's eye, leading the agency to issue a Sept. 10 "untitled" letter that cautions against promoting a drug like a cosmetic. This puts the drug maker in a tough position, considering Latisse sales are heavily reliant on consumer advertising.